User:Elizabeth Perkins

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Objectives of the Knight Cancer Institute Seminar Series)
(Objectives of the Knight Cancer Institute Seminar Series)
Line 85: Line 85:
Links to Archived Seminars:
Links to Archived Seminars:
 +
 +
November 15, 2011
 +
Alexander Gimelbrant, PhD
 +
"Autosomal Analog of X-Inactivation"
 +
 +
http://www.ohsu.edu/edcomm/flash/flash_player.php?params=1%60/res/kci/seminar111511.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%2011/15/11

Revision as of 15:00, 16 November 2011

Knight Cancer Institute Seminar Series

  • Charles Keller, MD Pediatric Cancer Biology Program
  • c/o Elizabeth Perkins, Administrative Coordinator
  • Oregon Health & Science University
  • Pape'Family Pediatric Research Institute
  • Mail Code: L321
  • 3181 SW Sam Jackson Park Road
  • Portland, OR 97239
  • 503-494-9962
  • perkinel@ohsu.edu

http://portal.ohsu.edu/blogs/researchnews/

Objectives of the Knight Cancer Institute Seminar Series

The 2nd Annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.


4:00pm TUESDAYS - OHSU MAIN HOSPITAL 8TH FLOOR CONFERENCE ROOM 8B60 -Schedule Subject to Chage-

October 4, 2011

Paul T. Spellman, PhD - OHSU


October 18, 2011

Ranadip Pal, PhD - Texas Tech


November 15, 2011

Alexander A. Gimelbrant, PhD - Dana Farber Cancer Institute


December 13, 2011

Bradley Bruce Olwin, PhD - Colorado University - Boulder


January 31, 2012

Mark Kieran, MD, PhD - Dana Farber Cancer Institute


February 21, 2012

Doug Yee, MD - Masonic Center University of Minnesota


February 28, 2012

Gordon B. Mills, MD, PhD - MD Anderson Cancer Center


March 27, 2012

Massimo Loda, MD - Dana-Farber Cancer Institute


March 13, 2012

Jeffrey M. Rosen, PhD - Baylor College of Medicine


April 17, 2012*

Elizabeth Blackburn, PhD - University of California San Francisco


April 24, 2012

Thomas A. Rando, MD, PhD - Stanford University School of Medicine


May 8, 2012

David M. Langenau, PhD - Massachusetts General Hospital

June 5, 2012 Stephano Cairo, PhD - Xentech

  • Location Changed to CHH 3171 1a / 3181 1b


Links to Archived Seminars:

November 15, 2011 Alexander Gimelbrant, PhD "Autosomal Analog of X-Inactivation"

http://www.ohsu.edu/edcomm/flash/flash_player.php?params=1%60/res/kci/seminar111511.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%2011/15/11


October 18, 2011 Ranadip Pal, PhD “Modeling Cancer Pathways: How Mathematical Modeling can Assist in Selecting & Predicting the Effectiveness of Targeted Drug Combinations”

http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/seminar101811.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20Oct.%2018%2C%202011

October 4, 2011 Paul T. Spellman, PhD “Systems Approaches to Understanding Cancer Biology & Treatment”

http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/seminar100411.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20Oct.%204%2C%202011

June 21, 2011 William Stratford May, MD, PhD “TNK1/KOS1: A Protein Tyrosine Kinase with a Tumor Suppressor Function”

http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/may062111.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%2C%20June%2021.%202011

June 14, 2011 James Ford, MD “Targeting DNA Repair for the Treatment and Prevention of Triple-Negative Breast Cancer”

http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/ford061411.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20June%2014%2C%202011

Personal tools